|
Hematology Conference 2025 "Case study on T-ALL, Biphenotypic leukemia, menin inhibitors" MOC ABIM II (8.27.25) |
08/27/2025 - 8:00am to 9:00am EDT |
|
Hematology Conference 2025 "Case study on T-ALL, Biphenotypic leukemia, menin inhibitors" MOC ABPATH (8.27.25) |
08/27/2025 - 8:00am to 9:00am EDT |
|
Hematology Conference 2025 "Autoimmune Conditions and CAR-T part 1" |
09/24/2025 - 8:00am to 9:00am EDT |
|
Hematology Conference 2025 "Autoimmune Conditions and CAR-T part 1" MOC ABPath (09.24.25) |
09/24/2025 - 8:00am to 9:00am EDT |
|
Hematology Conference 2025 "Autoimmune Conditions and CAR-T part 1" MOC ABIM II (09.24.25) |
09/24/2025 - 8:00am to 9:00am EDT |
|
2025 Evaluation_Hematology Conference |
09/29/2025 - 12:00am EDT to 10/31/2025 - 11:59pm EDT |
|
Hematology Conference 2025 "Autoimmune Conditions and CAR-T part 2" |
10/22/2025 - 8:00am to 9:00am EDT |
|
Hematology Conference 2025 "Autoimmune Conditions and CAR-T part 2" MOC ABPath (10.22.25) |
10/22/2025 - 8:00am to 9:00am EDT |
|
Hematology Conference 2025 "Autoimmune Conditions and CAR-T part 2" MOC ABIM II (10.22.25) |
10/22/2025 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward